Cargando…

Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient

Congenital thrombotic thrombocytopenic purpura (cTTP) is an inherited disease that is sometimes fatal in early childhood. cTTP is similar to idiopathic thrombotic thrombocytopenic purpura (iTTP); both are characterized by varying levels of thrombocytopenia, microangiopathic hemolytic anemia (MAHA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozano Jaramillo, Diego Alberto, Jimenez Ochoa, Marco Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425815/
https://www.ncbi.nlm.nih.gov/pubmed/34527101
http://dx.doi.org/10.14740/jmc3737
_version_ 1783749915508211712
author Lozano Jaramillo, Diego Alberto
Jimenez Ochoa, Marco Alejandro
author_facet Lozano Jaramillo, Diego Alberto
Jimenez Ochoa, Marco Alejandro
author_sort Lozano Jaramillo, Diego Alberto
collection PubMed
description Congenital thrombotic thrombocytopenic purpura (cTTP) is an inherited disease that is sometimes fatal in early childhood. cTTP is similar to idiopathic thrombotic thrombocytopenic purpura (iTTP); both are characterized by varying levels of thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and end-organ damage secondary to occlusion of the microvasculature. cTTP is caused by a partial or total deficiency or loss of function of ADAMTS-13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13). We report the case of a 33-year-old woman who was mistakenly diagnosed with primary immune thrombocytopenia (ITP) during childhood. The patient was referred to our center with dyspnea, fatigue, fever, and jaundice with no clinical bleeding. Laboratory features were compatible with MAHA; ADAMTS-13 activity was at 0%, with negativity for ADAMTS-13 antibodies. We concluded the final diagnosis was cTTP. The triggering factor identified for MAHA was a double infection: central venous catheter bacterial infection and atypical pneumonia. After 7 days of treatment with antibiotics and ongoing total plasma exchange (TPE), the patient responded favorably. Our patient received fresh frozen plasma (FFP) infusion once every 2 weeks, and prophylactic voriconazole remained under control at the time of writing. As demonstrated in this case, effective treatment of the trigger cause helps reduce the need for continuous FFP exposure and controls the MAHA.
format Online
Article
Text
id pubmed-8425815
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-84258152021-09-14 Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient Lozano Jaramillo, Diego Alberto Jimenez Ochoa, Marco Alejandro J Med Cases Case Report Congenital thrombotic thrombocytopenic purpura (cTTP) is an inherited disease that is sometimes fatal in early childhood. cTTP is similar to idiopathic thrombotic thrombocytopenic purpura (iTTP); both are characterized by varying levels of thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and end-organ damage secondary to occlusion of the microvasculature. cTTP is caused by a partial or total deficiency or loss of function of ADAMTS-13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13). We report the case of a 33-year-old woman who was mistakenly diagnosed with primary immune thrombocytopenia (ITP) during childhood. The patient was referred to our center with dyspnea, fatigue, fever, and jaundice with no clinical bleeding. Laboratory features were compatible with MAHA; ADAMTS-13 activity was at 0%, with negativity for ADAMTS-13 antibodies. We concluded the final diagnosis was cTTP. The triggering factor identified for MAHA was a double infection: central venous catheter bacterial infection and atypical pneumonia. After 7 days of treatment with antibiotics and ongoing total plasma exchange (TPE), the patient responded favorably. Our patient received fresh frozen plasma (FFP) infusion once every 2 weeks, and prophylactic voriconazole remained under control at the time of writing. As demonstrated in this case, effective treatment of the trigger cause helps reduce the need for continuous FFP exposure and controls the MAHA. Elmer Press 2021-09 2021-08-25 /pmc/articles/PMC8425815/ /pubmed/34527101 http://dx.doi.org/10.14740/jmc3737 Text en Copyright 2021, Lozano Jaramillo et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Lozano Jaramillo, Diego Alberto
Jimenez Ochoa, Marco Alejandro
Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient
title Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient
title_full Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient
title_fullStr Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient
title_full_unstemmed Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient
title_short Infection as Trigger for Congenital Thrombotic Thrombocytopenic Purpura in an Adult Patient
title_sort infection as trigger for congenital thrombotic thrombocytopenic purpura in an adult patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425815/
https://www.ncbi.nlm.nih.gov/pubmed/34527101
http://dx.doi.org/10.14740/jmc3737
work_keys_str_mv AT lozanojaramillodiegoalberto infectionastriggerforcongenitalthromboticthrombocytopenicpurpurainanadultpatient
AT jimenezochoamarcoalejandro infectionastriggerforcongenitalthromboticthrombocytopenicpurpurainanadultpatient